Literature DB >> 26206802

Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma.

Giovanni Riva1, Ivana Lagreca1, Adriana Mattiolo2, Daniela Belletti3, Laura Lignitto2, Patrizia Barozzi1, Barbara Ruozi3, Daniela Vallerini1, Chiara Quadrelli1, Giorgia Corradini1, Fabio Forghieri1, Roberto Marasca1, Franco Narni1, Giovanni Tosi3, Flavio Forni3, Maria Angela Vandelli3, Alberto Amadori4, Luigi Chieco-Bianchi5, Leonardo Potenza1, Maria Luisa Calabrò2, Mario Luppi6.   

Abstract

Entities:  

Keywords:  BLIMP1/PRDM1; PEL; RNAi; liposomes; siRNA

Mesh：

Substances：

Year:  2015        PMID： 26206802      PMCID： PMC4825307          DOI： 10.3324/haematol.2015.126854

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.

Authors:  M Luppi; R Trovato; P Barozzi; D Vallisa; G Rossi; A Re; L Ravazzini; L Potenza; G Riva; M Morselli; G Longo; L Cavanna; R Roncaglia; G Torelli
Journal:  Leukemia       Date:  2005-03       Impact factor: 11.528

Review 2.  KSHV/HHV8-associated lymphomas.

Authors:  Antonino Carbone; Annunziata Gloghini
Journal:  Br J Haematol       Date:  2007-11-07       Impact factor: 6.998

3.  Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA.

Authors:  Andrew Godfrey; John Anderson; Antigoni Papanastasiou; Yasu Takeuchi; Chris Boshoff
Journal:  Blood       Date:  2004-11-30       Impact factor: 22.113

4.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

5.  Safety and efficacy of RNAi therapy for transthyretin amyloidosis.

Authors:  Teresa Coelho; David Adams; Ana Silva; Pierre Lozeron; Philip N Hawkins; Timothy Mant; Javier Perez; Joseph Chiesa; Steve Warrington; Elizabeth Tranter; Malathy Munisamy; Rick Falzone; Jamie Harrop; Jeffrey Cehelsky; Brian R Bettencourt; Mary Geissler; James S Butler; Alfica Sehgal; Rachel E Meyers; Qingmin Chen; Todd Borland; Renta M Hutabarat; Valerie A Clausen; Rene Alvarez; Kevin Fitzgerald; Christina Gamba-Vitalo; Saraswathy V Nochur; Akshay K Vaishnaw; Dinah W Y Sah; Jared A Gollob; Ole B Suhr
Journal:  N Engl J Med       Date:  2013-08-29       Impact factor: 91.245

6.  Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile.

Authors:  Richard G Jenner; Karine Maillard; Nicola Cattini; Robin A Weiss; Chris Boshoff; Richard Wooster; Paul Kellam
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-18       Impact factor: 11.205

7.  Induction of apoptosis in plasma cells by B lymphocyte-induced maturation protein-1 knockdown.

Authors:  Fan-Ru Lin; Hui-Kai Kuo; Hsia-Yuan Ying; Fu-Hung Yang; Kuo-I Lin
Journal:  Cancer Res       Date:  2007-12-15       Impact factor: 12.701

8.  Antineoplastic activity of lentiviral vectors expressing interferon-alpha in a preclinical model of primary effusion lymphoma.

Authors:  Maria Luisa Calabrò; Paola Gasperini; Iole Maria Di Gangi; Stefano Indraccolo; Massimo Barbierato; Alberto Amadori; Luigi Chieco-Bianchi
Journal:  Blood       Date:  2009-02-04       Impact factor: 22.113

Review 9.  RNAi therapeutics: a potential new class of pharmaceutical drugs.

Authors:  David Bumcrot; Muthiah Manoharan; Victor Koteliansky; Dinah W Y Sah
Journal:  Nat Chem Biol       Date:  2006-12       Impact factor: 15.040

Review 10.  Knocking down barriers: advances in siRNA delivery.

Authors:  Kathryn A Whitehead; Robert Langer; Daniel G Anderson
Journal:  Nat Rev Drug Discov       Date:  2009-02       Impact factor: 84.694
View more
  2 in total

Review 1.  Human Herpesvirus 8 and Lymphoproliferative Disorders.

Authors:  Maria Luisa Calabrò; Ronit Sarid
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-11-01       Impact factor: 2.576

2.  Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors.

Authors:  Chong Wang; Luyao Zhang; Liangru Ke; Weiyue Ding; Sizun Jiang; Difei Li; Yohei Narita; Isabella Hou; Jun Liang; Shijun Li; Haipeng Xiao; Eva Gottwein; Kenneth M Kaye; Mingxiang Teng; Bo Zhao
Journal:  Nat Commun       Date:  2020-12-09       Impact factor: 14.919
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.